Open Demat Account

Bafna Pharmaceuticals -BAFNAPH Share Price

Sector: Pharmaceuticals

₹ 104.80

-4.85 (-4.42%)

CMPMay 07,2024 12:00 AM

Trade in Bafna Pharmaceuticals with IIFl Securities! Trade Now

Performance

Bafna Pharmaceuticals LTD KEY RATIOS

sector: Pharmaceuticals

  • CMP

    -

    -
  • Open
  • ₹ 113.00
  • Prev. Close
  • ₹ 109.65
  • Turnover(Lac.)
  • ₹ 21
  • Day's High
  • ₹ 113.00
  • Day's Low
  • ₹ 104.20
  • 52 Week's High
  • ₹ 124.45
  • 52 Week's Low
  • ₹ 75.90
  • Book Value
  • ₹ 34
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 248
  • P/E
  • 22.06
  • EPS
  • 4.76
  • Divi. Yield
  • 0

Bafna Pharmaceuticals LTD PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr. View All Peer Comparison

MORE ABOUT BAFNA PHARMACEUTICALS LTD

Summary

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a. Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern. During the year 2001, the company constructed a separate block at Madhavaram for man Read More


Reports by Bafna Pharmaceuticals LTD


Reports by Bafna Pharmaceuticals LTD

x